GlycoNex Incorporation (4168.TWO)
TWD 17.55
(-5.14%)
TWD 17.55
(-5.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.55 Billion TWD | -9.56% |
| 2022 | 1.71 Billion TWD | 23.08% |
| 2021 | 1.39 Billion TWD | -11.37% |
| 2020 | 1.57 Billion TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.41 Billion TWD | -7.16% |
| 2024 Q1 | 1.52 Billion TWD | -1.77% |
| 2023 FY | 1.55 Billion TWD | -9.56% |
| 2023 Q2 | 1.66 Billion TWD | 0.63% |
| 2023 Q1 | 1.65 Billion TWD | 0.0% |
| 2023 Q3 | 1.6 Billion TWD | -3.92% |
| 2023 Q4 | 1.55 Billion TWD | -3.05% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -140.803% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -26.686% |
| Visgeneer Inc. | 397.17 Million TWD | -290.964% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -36.951% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -949.667% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -133.603% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -64.884% |
| NaviFUS Corp. | 490.53 Million TWD | -216.555% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -47.819% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -33.896% |
| TaiRx, Inc. | 833.74 Million TWD | -86.245% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -13.895% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 56.827% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -2011.006% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 6.247% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -1112.691% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -170.931% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 46.471% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 28.078% |
| RBC Bioscience Corporation | 753.79 Million TWD | -106.001% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -379.045% |
| Level Biotechnology Inc. | 822.67 Million TWD | -88.752% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -16.434% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 60.122% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 58.816% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -310.404% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -278.497% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -107.437% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -415.83% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -182.974% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -193.457% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -291.284% |
| Neith Corporation | 192.15 Million TWD | -708.113% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 9.317% |
| VBI | 452.1 Million TWD | -243.465% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -486.727% |
| BiOptic Inc. | 613.77 Million TWD | -152.995% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 25.199% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -32.026% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 50.01% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -75.838% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 49.682% |
| AP Biosciences Inc | 890.75 Million TWD | -74.325% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -13.899% |
| EirGenix Inc. | 11.16 Billion TWD | 86.089% |
| Enimmune corporation | 604.82 Million TWD | -156.737% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -251.96% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 12.698% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -33.703% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -26.262% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 81.79% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 42.723% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 89.893% |
| TCI GENE Inc. | 1.16 Billion TWD | -33.181% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -427.126% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -122.323% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 60.727% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 59.379% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 72.29% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 74.513% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -46.215% |
| Acepodia, Inc. | 6.81 Billion TWD | 77.227% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 59.42% |